Discovery, development, commercialization of medicines in areas of unmet medical needs.
Issues related to FY2024 appropriations. Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169). Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to HIV. Issues related to intellectual property protections for COVID-19 vaccines and treatments.
BUD - Budget/Appropriations MMM - Medicare/Medicaid HCR - Health Issues TRD - Trade (domestic/foreign)
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
MATTHEW LEFFINGWELL JONATHON JONES BRYANT HALL COREY MALMGREN JOHN MICHAEL GONZALEZ JONATHON JONES BRYANT HALL COREY MALMGREN JOHN MICHAEL GONZALEZ JOHN MICHAEL GONZALEZ